Prospective cohort study of COPD patients from Maastricht area: the Maastricht COPD Cohort (MCC) - Maastricht COPD Cohort

CIRO+, expertisecentrum voor chronisch orgaanfalen0 个研究点目标入组 200 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•- Adults, either sex, older than 40 years of age;
•- Smoking history of 10 Pack Years or more;
•- Diagnosis of COPD stages I-IV as defined by the Global initiative for chronic Obstructive Lung Disease (GOLD);
•- Classified by COPD severity in group B or D, based on the GOLD criteria of COPD severity (Figure 1);
•- Patients must be able to complete diaries and quality of life questionnaires;
•- Patients must sign and date an informed consent prior to inclusion in the MCC.

•- Progressively fatal disease, or life expectancy *6 months;
•- Women who are breast feeding or are pregnant;
•- Patients with mental conditions rendering them unable to understand the nature, scope, and possible consequences of the study;
•- Patients unlikely to comply with the protocol, e.g., uncooperative attitude, inability to return for follow-up visits, and unlikelihood of completing the study;
•- Patients participating in an intervention study.

发起方

CIRO+, expertisecentrum voor chronisch orgaanfalen